先進藥物篩檢技術市場分析及預測（至2035年）：依類型、產品、技術、應用、形式、設備、製程、最終用戶及階段分類

預計到2034年，先進藥物篩檢技術市場規模將從2024年的77億美元成長至134億美元，複合年成長率約為6.3%。該市場涵蓋用於評估藥物療效和安全性的創新調查方法，例如高通量篩檢、基於細胞的檢測和In Silico模擬。這些技術透過提高準確性和縮短篩檢週期來加速藥物發現過程。推動市場成長的因素包括：對個人化醫療日益成長的需求、技術進步以及對藥物研發投入的不斷增加，這些因素共同促進了藥物研發過程的成長和創新。

受創新藥物發現方法迫切需求的推動，先進藥物篩檢技術市場正經歷強勁成長。基於細胞的檢測方法因其能夠提供更生理相關性的數據，成為成長最快的細分市場。該細分市場受益於3D細胞培養技術的進步，從而提高了預測準確性。高通量篩檢（HTS）是表現第二好的細分市場，這得益於其能夠快速且有效率地測試大規模庫。在HTS領域，自動化機器人系統日益普及，顯著提升了篩選速度和準確性。生化檢測方法也值得關注，尤其是酵素學檢測，它對於識別活性化合物至關重要。將人工智慧（AI）和機器學習技術融入篩檢流程正成為最佳化數據分析和決策的變革性趨勢。對個人化醫療的需求正在推動這些先進技術的應用，從而支撐著市場巨大的成長和創新潛力。

先進藥物篩檢技術市場產品種類繁多，主要廠商不斷推出創新解決方案，以滿足日益成長的高效篩檢方法需求。定價策略因地區而異，並受當地市場趨勢和競爭壓力的影響。快速藥物發現和開發的需求正推動市場轉型為更具成本效益的高通量篩檢技術。新興市場對這些先進技術的應用尤其強勁，這主要得益於不斷成長的醫藥投資和政府的支持政策。先進藥物篩檢技術市場的競爭異常激烈，各公司都在尋求透過技術創新和策略聯盟來實現差異化。監管影響至關重要，北美和歐洲嚴格的監管準則塑造競爭格​​局。基準研究表明，投資自動化和人工智慧驅動解決方案的公司正在獲得競爭優勢。個人化醫療和生物技術的進步正在推動市場需求，預計市場將顯著成長。儘管監管合規和高昂的初始成本等挑戰依然存在，但提高藥物療效和安全性的潛力為相關人員提供了盈利的機會。

主要趨勢和促進因素：

由於對個人化醫療和標靶治療的需求不斷成長，先進藥物篩檢技術市場正經歷強勁成長。關鍵趨勢包括將人工智慧 (AI) 和機器學習相結合，以提高篩檢的準確性和效率。這些技術加速了藥物發現過程，縮短了新療法的上市時間。此外，慢性病盛行率的上升以及對創新治療方案的需求也推動了市場擴張。高通量篩檢技術的進步是推動市場成長的主要因素，這些技術能夠快速分析大型化合物庫。這種能力對於識別有前景的候選藥物至關重要。此外，降低藥物研發成本和提高臨床試驗成功率的日益成長的需求也推動了先進篩檢方法的應用。監管機構對創新藥物開發方法的支持也促進了市場成長。新興市場擁有完善的醫療基礎設施和不斷成長的研發投入，蘊藏著許多機會。提供全面篩檢解決方案並利用最尖端科技的公司有望佔據顯著的市場佔有率。製藥公司與研究機構之間開放式創新和合作的趨勢進一步促進了藥物篩檢技術的進步。隨著對高效藥物發現流程的需求持續成長，預計該市場將繼續擴張。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

• 宏觀經濟分析
• 市場趨勢
• 市場促進因素
• 市場機遇
• 市場限制
• 複合年均成長率：成長分析
• 影響分析
• 新興市場
• 技術藍圖
• 戰略框架

第4章 細分市場分析

• 市場規模及預測：依類型
  • 生化篩檢
  • 基於細胞的檢測
  • In Silico篩檢
• 市場規模及預測：依產品分類
  • 試劑和耗材
  • 裝置
  • 軟體和服務
• 市場規模及預測：依技術分類
  • 高通量篩檢
  • 超高通量篩檢
  • 自動化液體處理
• 市場規模及預測：依應用領域分類
  • 製藥和生物技術公司
  • 學術和研究機構
  • 受託研究機構
• 市場規模及預測：依類型
  • 固相
  • 液相
• 市場規模及預測：依設備分類
  • 微孔盤讀數儀
  • 自動化系統
• 市場規模及預測：依製程分類
  • 鉛識別
  • 先導藥物最適化
  • 目標識別
• 市場規模及預測：依最終用戶分類
  • 醫院
  • 診斷檢查室
  • 研究中心
• 市場規模及預測：依階段分類
  • 藥物發現
  • 臨床前
  • 臨床

第5章 區域分析

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲地區
• 亞太地區
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲
  • 台灣
  • 亞太其他地區
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 義大利
  • 其他歐洲地區
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 撒哈拉以南非洲
  • 其他中東和非洲地區

第6章 市場策略

• 需求與供給差距分析
• 貿易和物流限制
• 價格、成本和利潤率趨勢
• 市場滲透率
• 消費者分析
• 法規概述

第7章 競爭訊息

• 市場定位
• 市場占有率
• 競爭基準
• 主要企業的策略

第8章：公司簡介

• Bio-Rad Laboratories
• Charles River Laboratories
• Perkin Elmer
• Eurofins Scientific
• Qiagen
• Agilent Technologies
• Thermo Fisher Scientific
• Evotec
• Illumina
• Promega Corporation
• Merck KGa A
• GE Healthcare
• Danaher Corporation
• Bruker Corporation
• Waters Corporation
• Shimadzu Corporation
• Bio-Techne
• Abcam
• Cell Signaling Technology
• Sartorius AG

第9章：關於我們

Advanced Drug Screening Techniques Market is anticipated to expand from $7.7 billion in 2024 to $13.4 billion by 2034, growing at a CAGR of approximately 6.3%. The Advanced Drug Screening Techniques Market encompasses innovative methodologies for evaluating drug efficacy and safety, including high-throughput screening, cell-based assays, and in silico modeling. These techniques accelerate drug discovery by enhancing precision and reducing development timelines. The market is driven by rising demand for personalized medicine, technological advancements, and increased investment in pharmaceutical R&D, fostering growth and innovation in drug development processes.

The Advanced Drug Screening Techniques Market is experiencing robust growth, fueled by the urgent need for innovative drug discovery methods. The cell-based assays segment is the top-performing sub-segment, driven by its ability to provide more physiologically relevant data. This segment benefits from advancements in 3D cell culture technologies, enhancing predictive accuracy. High-throughput screening (HTS) follows as the second highest-performing sub-segment, owing to its efficiency in rapidly testing large compound libraries. Within HTS, automated robotic systems are gaining prominence, offering increased speed and precision. The biochemical assays segment is also notable, especially in enzymatic assays, which are crucial for identifying active compounds. The integration of artificial intelligence and machine learning in screening processes is emerging as a transformative trend, optimizing data analysis and decision-making. The demand for personalized medicine is propelling the adoption of these advanced techniques, underscoring the market's potential for substantial growth and innovation.

The Advanced Drug Screening Techniques Market is characterized by a diverse array of product offerings, with several key players consistently launching innovative solutions to meet the growing demand for efficient screening methods. Pricing strategies vary significantly across regions, influenced by local market dynamics and competitive pressures. The market is seeing a shift towards more cost-effective and high-throughput screening technologies, driven by the need for rapid drug discovery and development. Emerging markets are particularly active in adopting these advanced techniques, spurred by increased pharmaceutical investments and supportive governmental policies. Competition within the Advanced Drug Screening Techniques Market is intense, with companies striving to differentiate through technological innovation and strategic partnerships. Regulatory influences play a pivotal role, with stringent guidelines in North America and Europe shaping the competitive landscape. Benchmarking indicates that firms investing in automation and AI-driven solutions are gaining a competitive edge. The market is poised for significant growth, with advancements in personalized medicine and biotechnology driving demand. Challenges such as regulatory compliance and high initial costs remain, yet the potential for enhanced drug efficacy and safety offers lucrative opportunities for stakeholders.

Geographical Overview:

The advanced drug screening techniques market is witnessing notable expansion across various regions, each presenting unique growth opportunities. North America leads, driven by technological advancements and a strong focus on drug discovery and development. Major pharmaceutical companies invest heavily in innovative screening technologies, bolstering the region's market position. Europe follows closely, with a robust regulatory framework and significant investments in research and development, fostering a conducive environment for market growth. The Asia Pacific region is rapidly emerging, propelled by increasing healthcare expenditure and the presence of numerous contract research organizations. Countries like China and India are at the forefront, offering cost-effective solutions and a skilled workforce. Latin America and the Middle East & Africa are nascent markets with promising potential. In Latin America, Brazil and Mexico are witnessing increased investments in healthcare infrastructure. Meanwhile, the Middle East & Africa region is recognizing the importance of advanced drug screening techniques in enhancing healthcare outcomes and driving innovation.

The Advanced Drug Screening Techniques Market is intricately affected by global tariffs, geopolitical risks, and evolving supply chain dynamics. In Japan and South Korea, the emphasis is on enhancing domestic capabilities to mitigate reliance on foreign technologies amidst escalating trade tensions. China, confronted with export barriers, is accelerating its investment in homegrown drug screening technologies to ensure self-sufficiency. Taiwan remains pivotal due to its advanced manufacturing prowess but is vulnerable to cross-strait tensions. Globally, the market is robust, driven by technological advancements and increasing healthcare demands. By 2035, the market is anticipated to flourish, contingent on strategic regional collaborations and resilient supply chains. Middle East conflicts pose a potential threat to energy prices, indirectly affecting operational costs and supply chain stability in the sector.

Key Trends and Drivers:

The Advanced Drug Screening Techniques Market is experiencing robust growth due to the rising demand for personalized medicine and targeted therapies. Key trends include the integration of artificial intelligence and machine learning to enhance screening accuracy and efficiency. These technologies enable faster drug discovery processes, reducing time-to-market for new therapies. Additionally, the increasing prevalence of chronic diseases and the need for innovative treatment solutions are propelling market expansion. Drivers of this market include advancements in high-throughput screening technologies, which allow for the rapid analysis of large compound libraries. This capability is crucial in identifying promising drug candidates. Furthermore, the growing focus on reducing drug development costs and improving success rates in clinical trials is encouraging the adoption of advanced screening methods. Regulatory support for innovative drug development approaches is also fostering market growth. Opportunities abound in emerging markets where healthcare infrastructure is improving, and investment in R&D is increasing. Companies that offer comprehensive screening solutions and leverage cutting-edge technologies are well-positioned to capture significant market share. The trend towards open innovation and collaboration among pharmaceutical companies and research institutions is further driving advancements in drug screening techniques. As the demand for effective and efficient drug discovery processes continues to grow, the market is set for sustained expansion.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Technology
• 2.4 Key Market Highlights by Application
• 2.5 Key Market Highlights by Form
• 2.6 Key Market Highlights by Device
• 2.7 Key Market Highlights by Process
• 2.8 Key Market Highlights by End User
• 2.9 Key Market Highlights by Stage

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Biochemical Screening
  • 4.1.2 Cell-based Assays
  • 4.1.3 In Silico Screening
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Reagents & Consumables
  • 4.2.2 Instruments
  • 4.2.3 Software & Services
• 4.3 Market Size & Forecast by Technology (2020-2035)
  • 4.3.1 High-Throughput Screening
  • 4.3.2 Ultra-High-Throughput Screening
  • 4.3.3 Automated Liquid Handling
• 4.4 Market Size & Forecast by Application (2020-2035)
  • 4.4.1 Pharmaceutical & Biotechnology Companies
  • 4.4.2 Academic & Research Institutes
  • 4.4.3 Contract Research Organizations
• 4.5 Market Size & Forecast by Form (2020-2035)
  • 4.5.1 Solid Phase
  • 4.5.2 Liquid Phase
• 4.6 Market Size & Forecast by Device (2020-2035)
  • 4.6.1 Microplate Readers
  • 4.6.2 Automated Systems
• 4.7 Market Size & Forecast by Process (2020-2035)
  • 4.7.1 Lead Identification
  • 4.7.2 Lead Optimization
  • 4.7.3 Target Identification
• 4.8 Market Size & Forecast by End User (2020-2035)
  • 4.8.1 Hospitals
  • 4.8.2 Diagnostic Laboratories
  • 4.8.3 Research Centers
• 4.9 Market Size & Forecast by Stage (2020-2035)
  • 4.9.1 Discovery
  • 4.9.2 Preclinical
  • 4.9.3 Clinical

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Technology
    • 5.2.1.4 Application
    • 5.2.1.5 Form
    • 5.2.1.6 Device
    • 5.2.1.7 Process
    • 5.2.1.8 End User
    • 5.2.1.9 Stage
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Technology
    • 5.2.2.4 Application
    • 5.2.2.5 Form
    • 5.2.2.6 Device
    • 5.2.2.7 Process
    • 5.2.2.8 End User
    • 5.2.2.9 Stage
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Technology
    • 5.2.3.4 Application
    • 5.2.3.5 Form
    • 5.2.3.6 Device
    • 5.2.3.7 Process
    • 5.2.3.8 End User
    • 5.2.3.9 Stage
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Technology
    • 5.3.1.4 Application
    • 5.3.1.5 Form
    • 5.3.1.6 Device
    • 5.3.1.7 Process
    • 5.3.1.8 End User
    • 5.3.1.9 Stage
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Technology
    • 5.3.2.4 Application
    • 5.3.2.5 Form
    • 5.3.2.6 Device
    • 5.3.2.7 Process
    • 5.3.2.8 End User
    • 5.3.2.9 Stage
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Technology
    • 5.3.3.4 Application
    • 5.3.3.5 Form
    • 5.3.3.6 Device
    • 5.3.3.7 Process
    • 5.3.3.8 End User
    • 5.3.3.9 Stage
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Technology
    • 5.4.1.4 Application
    • 5.4.1.5 Form
    • 5.4.1.6 Device
    • 5.4.1.7 Process
    • 5.4.1.8 End User
    • 5.4.1.9 Stage
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Technology
    • 5.4.2.4 Application
    • 5.4.2.5 Form
    • 5.4.2.6 Device
    • 5.4.2.7 Process
    • 5.4.2.8 End User
    • 5.4.2.9 Stage
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Technology
    • 5.4.3.4 Application
    • 5.4.3.5 Form
    • 5.4.3.6 Device
    • 5.4.3.7 Process
    • 5.4.3.8 End User
    • 5.4.3.9 Stage
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Technology
    • 5.4.4.4 Application
    • 5.4.4.5 Form
    • 5.4.4.6 Device
    • 5.4.4.7 Process
    • 5.4.4.8 End User
    • 5.4.4.9 Stage
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Technology
    • 5.4.5.4 Application
    • 5.4.5.5 Form
    • 5.4.5.6 Device
    • 5.4.5.7 Process
    • 5.4.5.8 End User
    • 5.4.5.9 Stage
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Technology
    • 5.4.6.4 Application
    • 5.4.6.5 Form
    • 5.4.6.6 Device
    • 5.4.6.7 Process
    • 5.4.6.8 End User
    • 5.4.6.9 Stage
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Technology
    • 5.4.7.4 Application
    • 5.4.7.5 Form
    • 5.4.7.6 Device
    • 5.4.7.7 Process
    • 5.4.7.8 End User
    • 5.4.7.9 Stage
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Technology
    • 5.5.1.4 Application
    • 5.5.1.5 Form
    • 5.5.1.6 Device
    • 5.5.1.7 Process
    • 5.5.1.8 End User
    • 5.5.1.9 Stage
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Technology
    • 5.5.2.4 Application
    • 5.5.2.5 Form
    • 5.5.2.6 Device
    • 5.5.2.7 Process
    • 5.5.2.8 End User
    • 5.5.2.9 Stage
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Technology
    • 5.5.3.4 Application
    • 5.5.3.5 Form
    • 5.5.3.6 Device
    • 5.5.3.7 Process
    • 5.5.3.8 End User
    • 5.5.3.9 Stage
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Technology
    • 5.5.4.4 Application
    • 5.5.4.5 Form
    • 5.5.4.6 Device
    • 5.5.4.7 Process
    • 5.5.4.8 End User
    • 5.5.4.9 Stage
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Technology
    • 5.5.5.4 Application
    • 5.5.5.5 Form
    • 5.5.5.6 Device
    • 5.5.5.7 Process
    • 5.5.5.8 End User
    • 5.5.5.9 Stage
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Technology
    • 5.5.6.4 Application
    • 5.5.6.5 Form
    • 5.5.6.6 Device
    • 5.5.6.7 Process
    • 5.5.6.8 End User
    • 5.5.6.9 Stage
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Technology
    • 5.6.1.4 Application
    • 5.6.1.5 Form
    • 5.6.1.6 Device
    • 5.6.1.7 Process
    • 5.6.1.8 End User
    • 5.6.1.9 Stage
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Technology
    • 5.6.2.4 Application
    • 5.6.2.5 Form
    • 5.6.2.6 Device
    • 5.6.2.7 Process
    • 5.6.2.8 End User
    • 5.6.2.9 Stage
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Technology
    • 5.6.3.4 Application
    • 5.6.3.5 Form
    • 5.6.3.6 Device
    • 5.6.3.7 Process
    • 5.6.3.8 End User
    • 5.6.3.9 Stage
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Technology
    • 5.6.4.4 Application
    • 5.6.4.5 Form
    • 5.6.4.6 Device
    • 5.6.4.7 Process
    • 5.6.4.8 End User
    • 5.6.4.9 Stage
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Technology
    • 5.6.5.4 Application
    • 5.6.5.5 Form
    • 5.6.5.6 Device
    • 5.6.5.7 Process
    • 5.6.5.8 End User
    • 5.6.5.9 Stage

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Bio- Rad Laboratories
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Charles River Laboratories
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Perkin Elmer
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Eurofins Scientific
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Qiagen
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Agilent Technologies
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Thermo Fisher Scientific
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Evotec
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Illumina
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Promega Corporation
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Merck KGa A
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 GE Healthcare
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Danaher Corporation
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Bruker Corporation
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Waters Corporation
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Shimadzu Corporation
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Bio- Techne
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Abcam
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Cell Signaling Technology
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Sartorius AG
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us